David Resnick is the team leader of the Patent group at Nixon Peabody LLP and he works with startup and established companies, as well as major U.S. research institutions, to develop comprehensive patent strategies to protect their intellectual property.

“My practice is focused on strategic portfolio management, patent prosecution, transactional matters and associated client counseling. I manage the patent portfolios of some of the leading U.S. research institutions and domestic and international corporations. I also represent some of the world’s most recognized life sciences corporations before the U.S. Patent and Trademark Office. I have extensive experience in the life sciences and have particular experience in the areas of pharmacogenomics, proteomics and disease biomarkers and their application in the evolving field of personalized medicine.”